Literature DB >> 3264291

Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.

R M Locksley1, S Crowe, M D Sadick, F P Heinzel, K D Gardner, M S McGrath, J Mills.   

Abstract

Infection of monocyte-macrophages with human immunodeficiency virus may be central to the pathogenesis of the acquired immunodeficiency syndrome. The ability of infected macrophages to prime T cells through IL-1 production was investigated in vitro. Purified human monocytes maintained in suspension culture were infected with strain HIV-DV. Intracellular expression of virus p24 antigen increased from undetectable levels immediately after infection to 13-59% of cells by 10-14 d; infected macrophages remained viable for up to 60 d. Supernatants collected between 14 and 20 d after infection were examined in the murine thymocyte co-mitogenesis assay and demonstrated to contain a potent IL-1 inhibitor, designated contra-IL-1. Contra-IL-1 activity was present in all supernatants examined after 4 d of infection, and peaked coincident with peak p24 antigen expression. Inhibitory activity was not present in uninfected cells. Contra-IL-1 activity eluted after gel filtration with an approximate molecular weight of 9 kD. Inhibitory activity was removed by exposure to heat or acid pH, or by incubation with chymotrypsin or staphylococcal V8 protease. Contra-IL-1 did not inhibit IL-2- or IL-4-dependent proliferation of murine T cell lines. Despite its ability to inhibit IL-1 activity, contra-IL-1 did not interfere with the binding of recombinant IL-1 beta to a fibroblast cell line. Contra-IL-1 inhibited the proliferation of normal peripheral blood mononuclear cells to both concanavalin A and tetanus toxoid; inhibition could be attenuated by the addition of exogenous IL-1. Messenger RNA extracted from infected macrophages was examined by Northern analysis for the presence of message to IL-1 beta. No message was apparent, suggesting that the presence of contra-IL-1 was not obscuring the concomitant release of IL-1. Infected macrophages stimulated with endotoxin generated readily detectable message for IL-1 beta. Spleen macrophages purified from two patients with AIDS complicated by immune thrombocytopenia spontaneously expressed p24 antigen in vitro and released contra-IL-1 activity into the media. Contra-IL-1 may contribute to the immune dysfunction of AIDS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264291      PMCID: PMC442793          DOI: 10.1172/JCI113831

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

2.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

3.  Reduced Langerhans' cell Ia antigen and ATPase activity in patients with the acquired immunodeficiency syndrome.

Authors:  D V Belsito; M R Sanchez; R L Baer; F Valentine; G J Thorbecke
Journal:  N Engl J Med       Date:  1984-05-17       Impact factor: 91.245

Review 4.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

5.  Demonstration of a circulating suppressor factor of thymocyte proliferation during endotoxin fever in humans.

Authors:  C A Dinarello; L J Rosenwasser; S M Wolff
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

6.  Identification of a specific interleukin 1 inhibitor in the urine of febrile patients.

Authors:  Z Liao; R S Grimshaw; D L Rosenstreich
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

7.  Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production.

Authors:  H W Murray; J K Hillman; B Y Rubin; C D Kelly; J L Jacobs; L W Tyler; D M Donelly; S M Carriero; J H Godbold; R B Roberts
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

8.  Purification and characterization of the RNA-directed DNA polymerase of a primate type-D retrovirus: Mason-Pfizer virus.

Authors:  D Colcher; J Schlom
Journal:  Biochim Biophys Acta       Date:  1980-05-30

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line.

Authors:  G Scala; Y D Kuang; R E Hall; A V Muchmore; J J Oppenheim
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  13 in total

1.  HIV-1 promotor insertion revealed by selective detection of chimeric provirus-host gene transcripts.

Authors:  I Raineri; H P Senn
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

2.  HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta.

Authors:  Hui Peng; Nathan Erdmann; Nicholas Whitney; Huangyu Dou; Santhi Gorantla; Howard E Gendelman; Anuja Ghorpade; Jialin Zheng
Journal:  Glia       Date:  2006-11-01       Impact factor: 7.452

3.  HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids.

Authors:  P Foley; F Kazazi; R Biti; T C Sorrell; A L Cunningham
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

4.  Human immunodeficiency virus type 1 enhances intracellular growth of Mycobacterium avium in human macrophages.

Authors:  G Källenius; T Koivula; K J Rydgård; S E Hoffner; A Valentin; B Asjö; C Ljungh; U Sharma; S B Svenson
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

5.  Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains.

Authors:  L Pulliam; B G Herndier; N M Tang; M S McGrath
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

6.  Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus.

Authors:  J M Molina; D T Scadden; R Byrn; C A Dinarello; J E Groopman
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

7.  Expression of interleukin 2 receptors by monocytes from patients with acquired immunodeficiency syndrome and induction of monocyte interleukin 2 receptors by human immunodeficiency virus in vitro.

Authors:  J B Allen; N McCartney-Francis; P D Smith; G Simon; S Gartner; L M Wahl; M Popovic; S M Wahl
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

8.  Activation of human monocyte--derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression.

Authors:  M S Bernstein; S E Tong-Starksen; R M Locksley
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

9.  Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2.

Authors:  A Ammar; Y Sahraoui; A Tsapis; A M Bertoli; C Jasmin; V Georgoulias
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

10.  During HIV-1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T cells clonal expansion.

Authors:  P U Cameron; U Forsum; H Teppler; A Granelli-Piperno; R M Steinman
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.